ABOUT THIS EPISODE
Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma companies, particularly those focused on rare diseases. Andy explains how ADVANZ uses data to prepare for a launch, scale across multiple markets, and help MSLs get up-to-speed quickly for an in-depth scientific discussion with experts.
English
United States
TRANSCRIPT 🔗
1
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
00:00:00,208 --> 00:00:03,375
(bright upbeat music)
2
00:00:08,640 --> 00:00:10,620
- Hello everyone, and thank you very much
3
00:00:10,620 --> 00:00:13,443
for joining today's podcast episode.
4
00:00:14,340 --> 00:00:15,990
We have an exciting topic today.
5
00:00:15,990 --> 00:00:19,260
We're going to be talking
about launch in commercial
6
00:00:19,260 --> 00:00:21,270
and specifically in rare diseases,
7
00:00:21,270 --> 00:00:24,360
and I'm very, very
pleased to be joined today
8
00:00:…
SEARCH PAST EPISODES
Search past episodes of What Pharma Needs Next.
Disclaimer: The podcast and artwork embedded on this page are from Veeva Systems, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.